TreeWAS – Variant ID: rs147213018

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z83.5 Family history of eye and ear disorders	0.042	0.958	0.000
Z83 Family history of other specific disorders	0.024	0.976	0.000
C54.1 Endometrium	0.000	0.978	0.022
Z83.4 Family history of other endocrine, nutritional and metabolic diseases	0.019	0.980	0.000
Z83.3 Family history of diabetes mellitus	0.019	0.981	0.000
Z83.1 Family history of other infectious and parasitic diseases	0.018	0.982	0.000
Z83.2 Family history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.018	0.982	0.000
T43.2 Other and unspecified antidepressants	0.017	0.983	0.000
Z83.6 Family history of diseases of the respiratory system	0.017	0.983	0.000
Z83.0 Family history of human immunodeficiency virus [HIV]	0.017	0.983	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.014	0.986	0.000
Z83.7 Family history of diseases of the digestive system	0.013	0.987	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.013	0.987	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.013	0.987	0.000
T43.9 Psychotropic drug, unspecified	0.010	0.989	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.010	0.989	0.000
T43.6 Psychostimulants with abuse potential	0.010	0.989	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.010	0.989	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.010	0.989	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.010	0.990	0.000
C54 Malignant neoplasm of corpus uteri	0.000	0.991	0.009
C54.8 Overlapping lesion of corpus uteri	0.000	0.993	0.007
C54.3 Fundus uteri	0.000	0.993	0.007
C54.2 Myometrium	0.000	0.993	0.007
C54.0 Isthmus uteri	0.000	0.993	0.007
F33.9 Recurrent depressive disorder, unspecified	0.007	0.993	0.000
C54.9 Corpus uteri, unspecified	0.000	0.993	0.007
G25.0 Essential tremor	0.006	0.994	0.000
E27.1 Primary adrenocortical insufficiency	0.006	0.994	0.000
R04.2 Haemoptysis	0.005	0.995	0.000
I78.1 Naevus, nonneoplastic	0.005	0.995	0.000
F33 Recurrent depressive disorder	0.005	0.995	0.000
E27 Other disorders of adrenal gland	0.004	0.996	0.000
G25 Other extrapyramidal and movement disorders	0.004	0.996	0.000
M46.99 Inflammatory spondylopathy, unspecified (Site unspecified)	0.004	0.996	0.000
E27.2 Addisonian crisis	0.004	0.996	0.000
G25.8 Other specified extrapyramidal and movement disorders	0.004	0.996	0.000
K82.8 Other specified diseases of gallbladder	0.000	0.996	0.004
R94.5 Abnormal results of liver function studies	0.004	0.996	0.000
E23.0 Hypopituitarism	0.004	0.996	0.000
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.004	0.996	0.000
F31 Bipolar affective disorder	0.004	0.996	0.000
E20-E35 Disorders of other endocrine glands	0.004	0.996	0.000
F33.8 Other recurrent depressive disorders	0.003	0.996	0.000
F33.4 Recurrent depressive disorder, currently in remission	0.003	0.996	0.000
F30-F39 Mood [affective] disorders	0.004	0.996	0.000
F33.0 Recurrent depressive disorder, current episode mild	0.003	0.996	0.000
E23 Hypofunction and other disorders of pituitary gland	0.003	0.996	0.000
F31.9 Bipolar affective disorder, unspecified	0.003	0.997	0.000
G25.3 Myoclonus	0.003	0.997	0.000
E27.5 Adrenomedullary hyperfunction	0.003	0.997	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.003	0.997	0.000
E27.0 Other adrenocortical overactivity	0.003	0.997	0.000
F30.9 Manic episode, unspecified	0.003	0.997	0.000
E34 Other endocrine disorders	0.003	0.997	0.000
T45.0 Antiallergic and antiemetic drugs	0.003	0.997	0.000
E27.8 Other specified disorders of adrenal gland	0.003	0.997	0.000
F30 Manic episode	0.003	0.997	0.000
G25.9 Extrapyramidal and movement disorder, unspecified	0.003	0.997	0.000
G25.6 Drug-induced tics and other tics of organic origin	0.003	0.997	0.000
G25.5 Other chorea	0.003	0.997	0.000
G25.4 Drug-induced chorea	0.003	0.997	0.000
G25.2 Other specified forms of tremor	0.003	0.997	0.000
G25.1 Drug-induced tremor	0.003	0.997	0.000
E34.9 Endocrine disorder, unspecified	0.003	0.997	0.000
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.003	0.997	0.000
E27.9 Disorder of adrenal gland, unspecified	0.003	0.997	0.000
E25 Adrenogenital disorders	0.003	0.997	0.000
F33.1 Recurrent depressive disorder, current episode moderate	0.003	0.997	0.000
E26 Hyperaldosteronism	0.003	0.997	0.000
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.003	0.997	0.000
E29 Testicular dysfunction	0.003	0.997	0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.003	0.997	0.000
R39.1 Other difficulties with micturition	0.003	0.997	0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.003	0.997	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.003	0.997	0.000
F31.8 Other bipolar affective disorders	0.003	0.997	0.000
F31.7 Bipolar affective disorder, currently in remission	0.003	0.997	0.000
E24 Cushing's syndrome	0.003	0.997	0.000
F31.6 Bipolar affective disorder, current episode mixed	0.003	0.997	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.003	0.997	0.000
E32 Diseases of thymus	0.003	0.997	0.000
E31 Polyglandular dysfunction	0.003	0.997	0.000
E30 Disorders of puberty, not elsewhere classified	0.003	0.997	0.000
S02.20 Fracture of nasal bones (closed)	0.000	0.997	0.003
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)	0.003	0.997	0.000
F31.0 Bipolar affective disorder, current episode hypomanic	0.003	0.997	0.000
E23.7 Disorder of pituitary gland, unspecified	0.003	0.997	0.000
E26.0 Primary hyperaldosteronism	0.003	0.997	0.000
F38 Other mood [affective] disorders	0.003	0.997	0.000
E29.1 Testicular hypofunction	0.003	0.997	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.003	0.997	0.000
E23.1 Drug-induced hypopituitarism	0.003	0.997	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.003	0.997	0.000
E34.0 Carcinoid syndrome	0.003	0.997	0.000
E28 Ovarian dysfunction	0.003	0.997	0.000
F34 Persistent mood [affective] disorders	0.003	0.997	0.000
F39 Unspecified mood [affective] disorder	0.003	0.997	0.000
I78 Diseases of capillaries	0.003	0.997	0.000
S02.80 Fractures of other skull and facial bones (closed)	0.000	0.997	0.003
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.003	0.997	0.000
E34.8 Other specified endocrine disorders	0.003	0.997	0.000
E34.5 Androgen resistance syndrome	0.003	0.997	0.000
E34.4 Constitutional tall stature	0.003	0.997	0.000
E34.3 Short stature, not elsewhere classified	0.003	0.997	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.003	0.997	0.000
E34.1 Other hypersecretion of intestinal hormones	0.003	0.997	0.000
S02.60 Fracture of mandible (closed)	0.000	0.997	0.003
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.003	0.997	0.000
S02.2 Fracture of nasal bones	0.000	0.997	0.003
F30.8 Other manic episodes	0.002	0.997	0.000
F30.2 Mania with psychotic symptoms	0.002	0.997	0.000
F30.1 Mania without psychotic symptoms	0.002	0.997	0.000
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.003	0.997	0.000
R57.2 Septic shock	0.003	0.997	0.000
E20 Hypoparathyroidism	0.003	0.997	0.000
S02.8 Fractures of other skull and facial bones	0.000	0.997	0.003
E28.3 Primary ovarian failure	0.003	0.997	0.000
S02.40 Fracture of malar and maxillary bones (closed)	0.000	0.997	0.003
E23.6 Other disorders of pituitary gland	0.002	0.997	0.000
K56.4 Other impaction of intestine	0.000	0.997	0.003
S02.6 Fracture of mandible	0.000	0.997	0.003
E25.9 Adrenogenital disorder, unspecified	0.002	0.997	0.000
E25.8 Other adrenogenital disorders	0.002	0.997	0.000
S02 Fracture of skull and facial bones	0.000	0.997	0.003
T36-T50 Poisoning by drugs, medicaments and biological substances	0.003	0.997	0.000
S02.4 Fracture of malar and maxillary bones	0.000	0.997	0.003
E23.2 Diabetes insipidus	0.002	0.997	0.000
E24.2 Drug-induced Cushing's syndrome	0.002	0.997	0.000
E26.9 Hyperaldosteronism, unspecified	0.002	0.997	0.000
E26.8 Other hyperaldosteronism	0.002	0.997	0.000
E26.1 Secondary hyperaldosteronism	0.002	0.997	0.000
E29.9 Testicular dysfunction, unspecified	0.002	0.997	0.000
E29.8 Other testicular dysfunction	0.002	0.997	0.000
E29.0 Testicular hyperfunction	0.002	0.997	0.000
B37.9 Candidiasis, unspecified	0.000	0.998	0.002
T45.5 Anticoagulants	0.002	0.998	0.000
S06.80 Other intracranial injuries (without open intracranial wound)	0.002	0.998	0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.000	0.998	0.002
I78.0 Hereditary haemorrhagic telangiectasia	0.002	0.998	0.000
S02.3 Fracture of orbital floor	0.000	0.998	0.002
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.002	0.998	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.002	0.998	0.000
T45.8 Other primarily systemic and haematological agents	0.002	0.998	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
T45.6 Fibrinolysis-affecting drugs	0.002	0.998	0.000
T45.4 Iron and its compounds	0.002	0.998	0.000
T45.3 Enzymes, not elsewhere classified	0.002	0.998	0.000
T45.2 Vitamins, not elsewhere classified	0.002	0.998	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.002	0.998	0.000
Q05.9 Spina bifida, unspecified	0.002	0.998	0.000
S02.30 Fracture of orbital floor (closed)	0.000	0.998	0.002
E24.8 Other Cushing's syndrome	0.002	0.998	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.002	0.998	0.000
E24.3 Ectopic ACTH syndrome	0.002	0.998	0.000
E24.1 Nelson's syndrome	0.002	0.998	0.000
E24.0 Pituitary-dependent Cushing's disease	0.002	0.998	0.000
E30.9 Disorder of puberty, unspecified	0.002	0.998	0.000
E30.8 Other disorders of puberty	0.002	0.998	0.000
E30.1 Precocious puberty	0.002	0.998	0.000
E30.0 Delayed puberty	0.002	0.998	0.000
E31.9 Polyglandular dysfunction, unspecified	0.002	0.998	0.000
E31.8 Other polyglandular dysfunction	0.002	0.998	0.000
E31.1 Polyglandular hyperfunction	0.002	0.998	0.000
E31.0 Autoimmune polyglandular failure	0.002	0.998	0.000
E32.9 Disease of thymus, unspecified	0.002	0.998	0.000
E32.8 Other diseases of thymus	0.002	0.998	0.000
E32.1 Abscess of thymus	0.002	0.998	0.000
E32.0 Persistent hyperplasia of thymus	0.002	0.998	0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.002	0.998	0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.002	0.998	0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.002	0.998	0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.000	0.998	0.002
E22 Hyperfunction of pituitary gland	0.002	0.998	0.000
F38.8 Other specified mood [affective] disorders	0.002	0.998	0.000
F38.1 Other recurrent mood [affective] disorders	0.002	0.998	0.000
F38.0 Other single mood [affective] disorders	0.002	0.998	0.000
S02.5 Fracture of tooth	0.000	0.998	0.002
E28.9 Ovarian dysfunction, unspecified	0.002	0.998	0.000
E28.8 Other ovarian dysfunction	0.002	0.998	0.000
E28.1 Androgen excess	0.002	0.998	0.000
E28.0 Oestrogen excess	0.002	0.998	0.000
F30.0 Hypomania	0.002	0.998	0.000
F34.9 Persistent mood [affective] disorder, unspecified	0.002	0.998	0.000
F34.8 Other persistent mood [affective] disorders	0.002	0.998	0.000
F34.0 Cyclothymia	0.002	0.998	0.000
I78.9 Disease of capillaries, unspecified	0.002	0.998	0.000
I78.8 Other diseases of capillaries	0.002	0.998	0.000
F32.3 Severe depressive episode with psychotic symptoms	0.002	0.998	0.000
F34.1 Dysthymia	0.002	0.998	0.000
K56.1 Intussusception	0.000	0.998	0.002
Y40.0 Penicillins	0.000	0.998	0.002
F32 Depressive episode	0.002	0.998	0.000
S02.21 Fracture of nasal bones (open)	0.000	0.998	0.002
E20.8 Other hypoparathyroidism	0.002	0.998	0.000
E20.1 Pseudohypoparathyroidism	0.002	0.998	0.000
E20.0 Idiopathic hypoparathyroidism	0.002	0.998	0.000
O75.8 Other specified complications of labour and delivery	0.002	0.998	0.000
S02.81 Fractures of other skull and facial bones (open)	0.000	0.998	0.002
E21.3 Hyperparathyroidism, unspecified	0.002	0.998	0.000
S02.61 Fracture of mandible (open)	0.000	0.998	0.002
K56.2 Volvulus	0.000	0.998	0.002
S02.9 Fracture of skull and facial bones, part unspecified	0.000	0.998	0.002
F32.2 Severe depressive episode without psychotic symptoms	0.002	0.998	0.000
S02.41 Fracture of malar and maxillary bones (open)	0.000	0.998	0.002
M46.9 Inflammatory spondylopathy, unspecified	0.002	0.998	0.000
S02.7 Multiple fractures involving skull and facial bones	0.000	0.998	0.002
S06.6 Traumatic subarachnoid haemorrhage	0.002	0.998	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.002	0.998	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.002	0.998	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.000	0.998	0.002
S02.50 Fracture of tooth (closed)	0.000	0.998	0.002
E24.9 Cushing's syndrome, unspecified	0.002	0.998	0.000
Z74.0 Reduced mobility	0.000	0.998	0.002
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
T36 Poisoning by systemic antibiotics	0.002	0.998	0.000
K56 Paralytic ileus and intestinal obstruction without hernia	0.000	0.998	0.002
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.002	0.998	0.000
S02.31 Fracture of orbital floor (open)	0.000	0.998	0.002
E21.5 Disorder of parathyroid gland, unspecified	0.002	0.998	0.000
E21.4 Other specified disorders of parathyroid gland	0.002	0.998	0.000
E21.2 Other hyperparathyroidism	0.002	0.998	0.000
S92.30 Fracture of metatarsal bone (closed)	0.002	0.998	0.000
M89.87 Other specified disorders of bone (Ankle and foot)	0.002	0.998	0.000
E20.9 Hypoparathyroidism, unspecified	0.002	0.998	0.000
H81.1 Benign paroxysmal vertigo	0.002	0.998	0.000
M06.9 Rheumatoid arthritis, unspecified	0.000	0.998	0.002
S06.8 Other intracranial injuries	0.002	0.998	0.000
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.000	0.998	0.002
E22.9 Hyperfunction of pituitary gland, unspecified	0.002	0.998	0.000
E22.8 Other hyperfunction of pituitary gland	0.002	0.998	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
S02.51 Fracture of tooth (open)	0.000	0.998	0.002
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.002	0.998	0.000
E22.1 Hyperprolactinaemia	0.002	0.998	0.000
K56.0 Paralytic ileus	0.000	0.998	0.002
M89.85 Other specified disorders of bone (Pelvic region and thigh)	0.002	0.998	0.000
F32.8 Other depressive episodes	0.002	0.998	0.000
Q63.0 Accessory kidney	0.002	0.998	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.002	0.998	0.000
M89.97 Disorder of bone, unspecified (Ankle and foot)	0.002	0.998	0.000
M89.8 Other specified disorders of bone	0.002	0.998	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
I61.1 Intracerebral haemorrhage in hemisphere, cortical	0.002	0.998	0.000
N83.1 Corpus luteum cyst	0.002	0.998	0.000
Q87.4 Marfan's syndrome	0.002	0.998	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.002	0.998	0.000
S02.90 Fracture of skull and facial bones, part unspecified (closed)	0.000	0.998	0.002
Q05 Spina bifida	0.002	0.998	0.000
M46.97 Inflammatory spondylopathy, unspecified (Lumbosacral region)	0.002	0.998	0.000
M89.84 Other specified disorders of bone (Hand)	0.002	0.998	0.000
S02.91 Fracture of skull and facial bones, part unspecified (open)	0.000	0.998	0.002
S02.1 Fracture of base of skull	0.000	0.998	0.002
S02.0 Fracture of vault of skull	0.000	0.998	0.002
M46.98 Inflammatory spondylopathy, unspecified (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M46.95 Inflammatory spondylopathy, unspecified (Thoracolumbar region)	0.002	0.998	0.000
M46.94 Inflammatory spondylopathy, unspecified (Thoracic region)	0.002	0.998	0.000
M46.93 Inflammatory spondylopathy, unspecified (Cervicothoracic region)	0.002	0.998	0.000
M46.91 Inflammatory spondylopathy, unspecified (Occipito-atlanto-axial region)	0.002	0.998	0.000
M46.90 Inflammatory spondylopathy, unspecified (Multiple sites in spine)	0.002	0.998	0.000
S02.71 Multiple fractures involving skull and facial bones (open)	0.000	0.998	0.002
S02.70 Multiple fractures involving skull and facial bones (closed)	0.000	0.998	0.002
S06.61 Traumatic subarachnoid haemorrhage (with open intracranial wound)	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
T37.5 Antiviral drugs	0.002	0.998	0.000
T37.4 Anthelminthics	0.002	0.998	0.000
T37.3 Other antiprotozoal drugs	0.002	0.998	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
T37.1 Antimycobacterial drugs	0.002	0.998	0.000
T37.0 Sulphonamides	0.002	0.998	0.000
T41.5 Therapeutic gases	0.002	0.998	0.000
T41.4 Anaesthetic, unspecified	0.002	0.998	0.000
T41.3 Local anaesthetics	0.002	0.998	0.000
T41.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
T41.1 Intravenous anaesthetics	0.002	0.998	0.000
T41.0 Inhaled anaesthetics	0.002	0.998	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
T48.5 Anti-common-cold drugs	0.002	0.998	0.000
T48.4 Expectorants	0.002	0.998	0.000
T48.3 Antitussives	0.002	0.998	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
T48.0 Oxytocic drugs	0.002	0.998	0.000
T49.9 Topical agent, unspecified	0.002	0.998	0.000
T49.8 Other topical agents	0.002	0.998	0.000
T49.7 Dental drugs, topically applied	0.002	0.998	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
T49.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
T49.3 Emollients, demulcents and protectants	0.002	0.998	0.000
T49.2 Local astringents and local detergents	0.002	0.998	0.000
T49.1 Antipruritics	0.002	0.998	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
T50.8 Diagnostic agents	0.002	0.998	0.000
T50.7 Analeptics and opioid receptor antagonists	0.002	0.998	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
T50.5 Appetite depressants	0.002	0.998	0.000
T50.4 Drugs affecting uric acid metabolism	0.002	0.998	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.002	0.998	0.000
T50.1 Loop [high-ceiling] diuretics	0.002	0.998	0.000
T50.0 Mineralocorticoids and their antagonists	0.002	0.998	0.000
R57.0 Cardiogenic shock	0.002	0.998	0.000
T36.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
T36.8 Other systemic antibiotics	0.002	0.998	0.000
T36.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
T36.6 Rifamycins	0.002	0.998	0.000
T36.5 Aminoglycosides	0.002	0.998	0.000
T36.4 Tetracyclines	0.002	0.998	0.000
T36.3 Macrolides	0.002	0.998	0.000
T36.2 Chloramphenicol group	0.002	0.998	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.002	0.998	0.000
K56.5 Intestinal adhesions [bands] with obstruction	0.000	0.998	0.002
K56.3 Gallstone ileus	0.000	0.998	0.002
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.998	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
T44.0 Anticholinesterase agents	0.002	0.998	0.000
E28.2 Polycystic ovarian syndrome	0.001	0.998	0.000
M17.1 Other primary gonarthrosis	0.002	0.998	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.001	0.998	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.001	0.998	0.000
T47.7 Emetics	0.001	0.998	0.000
T47.6 Antidiarrhoeal drugs	0.001	0.998	0.000
T47.5 Digestants	0.001	0.998	0.000
T47.4 Other laxatives	0.001	0.998	0.000
T47.3 Saline and osmotic laxatives	0.001	0.998	0.000
T47.2 Stimulant laxatives	0.001	0.998	0.000
T47.0 Histamine H(2)-receptor antagonists	0.001	0.998	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.000	0.998	0.002
M89.03 Algoneurodystrophy (Forearm)	0.002	0.998	0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.002	0.998	0.000
F32.0 Mild depressive episode	0.002	0.998	0.000
K09.0 Developmental odontogenic cysts	0.002	0.998	0.000
H11.4 Other conjunctival vascular disorders and cysts	0.002	0.998	0.000
N85.0 Endometrial glandular hyperplasia	0.000	0.998	0.002
J61 Pneumoconiosis due to asbestos and other mineral fibres	0.002	0.998	0.000
S06.81 Other intracranial injuries (with open intracranial wound)	0.001	0.998	0.000
E22.0 Acromegaly and pituitary gigantism	0.001	0.998	0.000
M89.0 Algoneurodystrophy	0.002	0.998	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
F40.2 Specific (isolated) phobias	0.002	0.998	0.000
T36.0 Penicillins	0.001	0.998	0.000
T38.9 Other and unspecified hormone antagonists	0.001	0.998	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.001	0.998	0.000
T38.7 Androgens and anabolic congeners	0.001	0.998	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.001	0.998	0.000
T38.5 Other oestrogens and progestogens	0.001	0.998	0.000
T38.4 Oral contraceptives	0.001	0.998	0.000
T38.2 Antithyroid drugs	0.001	0.998	0.000
T38.1 Thyroid hormones and substitutes	0.001	0.998	0.000
T38.0 Glucocorticoids and synthetic analogues	0.001	0.998	0.000
H81.2 Vestibular neuronitis	0.002	0.998	0.000
M06.98 Rheumatoid arthritis, unspecified (Other)	0.000	0.998	0.002
M46.96 Inflammatory spondylopathy, unspecified (Lumbar region)	0.001	0.998	0.000
M89.89 Other specified disorders of bone (Site unspecified)	0.001	0.998	0.000
M89.83 Other specified disorders of bone (Forearm)	0.001	0.998	0.000
M89.82 Other specified disorders of bone (Upper arm)	0.001	0.998	0.000
M89.81 Other specified disorders of bone (Shoulder region)	0.001	0.998	0.000
M89.80 Other specified disorders of bone (Multiple sites)	0.001	0.998	0.000
M89.9 Disorder of bone, unspecified	0.002	0.998	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.001	0.998	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.001	0.998	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.001	0.998	0.000
T42.3 Barbiturates	0.001	0.998	0.000
T42.2 Succinimides and oxazolidinediones	0.001	0.998	0.000
T42.1 Iminostilbenes	0.002	0.998	0.000
T42.0 Hydantoin derivatives	0.001	0.998	0.000
R57 Shock, not elsewhere classified	0.002	0.998	0.000
H11.3 Conjunctival haemorrhage	0.002	0.998	0.000
O75.2 Pyrexia during labour, not elsewhere classified	0.002	0.998	0.000
R46.2 Strange and inexplicable behaviour	0.002	0.998	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.001	0.998	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.001	0.998	0.000
T46.7 Peripheral vasodilators	0.001	0.998	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.001	0.998	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.001	0.998	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.001	0.998	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.001	0.998	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.001	0.998	0.000
Z40.0 Prophylactic surgery for risk-factors related to malignant neoplasms	0.002	0.998	0.000
M89 Other disorders of bone	0.002	0.998	0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.000	0.998	0.002
Z63.4 Disappearance and death of family member	0.002	0.998	0.000
Z63 Other problems related to primary support group, including family circumstances	0.002	0.998	0.000
S02.01 Fracture of vault of skull (open)	0.000	0.998	0.001
D46.9 Myelodysplastic syndrome, unspecified	0.000	0.998	0.002
K56.7 Ileus, unspecified	0.000	0.998	0.002
Q05.8 Sacral spina bifida without hydrocephalus	0.001	0.998	0.000
Q05.7 Lumbar spina bifida without hydrocephalus	0.001	0.998	0.000
Q05.6 Thoracic spina bifida without hydrocephalus	0.001	0.998	0.000
Q05.5 Cervical spina bifida without hydrocephalus	0.001	0.998	0.000
Q05.4 Unspecified spina bifida with hydrocephalus	0.001	0.998	0.000
Q05.3 Sacral spina bifida with hydrocephalus	0.001	0.998	0.000
Q05.2 Lumbar spina bifida with hydrocephalus	0.001	0.998	0.000
Q05.1 Thoracic spina bifida with hydrocephalus	0.001	0.998	0.000
Q05.0 Cervical spina bifida with hydrocephalus	0.001	0.998	0.000
Z63.0 Problems in relationship with spouse or partner	0.002	0.998	0.000
C51-C58 Malignant neoplasms of female genital organs	0.000	0.998	0.002
S02.11 Fracture of base of skull (open)	0.000	0.998	0.001
F60.9 Personality disorder, unspecified	0.002	0.998	0.000
K62.7 Radiation proctitis	0.000	0.998	0.002
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.002	0.998	0.000
Z59.8 Other problems relating to housing and economic circumstances	0.001	0.998	0.000
M89.88 Other specified disorders of bone (Other)	0.001	0.998	0.000
H11.8 Other specified disorders of conjunctiva	0.001	0.998	0.000
M89.06 Algoneurodystrophy (Lower leg)	0.001	0.998	0.000
F32.1 Moderate depressive episode	0.001	0.998	0.000
G62.8 Other specified polyneuropathies	0.002	0.998	0.000
Z63.5 Disruption of family by separation and divorce	0.001	0.998	0.000
Q87 Other specified congenital malformation syndromes affecting multiple systems	0.001	0.998	0.000
S06 Intracranial injury	0.002	0.998	0.000
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.000	0.998	0.001
M25.55 Pain in joint (Pelvic region and thigh)	0.002	0.998	0.000
Z59.9 Problem relating to housing and economic circumstances, unspecified	0.001	0.998	0.000
S06.90 Intracranial injury, unspecified (without open intracranial wound)	0.001	0.998	0.000
I61.0 Intracerebral haemorrhage in hemisphere, subcortical	0.001	0.998	0.000
R46.8 Other symptoms and signs involving appearance and behaviour	0.001	0.998	0.000
S06.9 Intracranial injury, unspecified	0.001	0.998	0.000
T46.1 Calcium-channel blockers	0.001	0.998	0.000
Z63.7 Other stressful life events affecting family and household	0.001	0.998	0.000
H81 Disorders of vestibular function	0.002	0.998	0.000
Q63 Other congenital malformations of kidney	0.001	0.998	0.000
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)	0.001	0.998	0.000
M89.09 Algoneurodystrophy (Site unspecified)	0.001	0.999	0.000
M89.08 Algoneurodystrophy (Other)	0.001	0.999	0.000
M89.07 Algoneurodystrophy (Ankle and foot)	0.001	0.999	0.000
M89.05 Algoneurodystrophy (Pelvic region and thigh)	0.001	0.999	0.000
M89.04 Algoneurodystrophy (Hand)	0.001	0.999	0.000
M89.02 Algoneurodystrophy (Upper arm)	0.001	0.999	0.000
M89.01 Algoneurodystrophy (Shoulder region)	0.001	0.999	0.000
M89.00 Algoneurodystrophy (Multiple sites)	0.001	0.999	0.000
I61.5 Intracerebral haemorrhage, intraventricular	0.001	0.999	0.000
J67.9 Hypersensitivity pneumonitis due to unspecified organic dust	0.001	0.999	0.000
Y40.9 Systemic antibiotic, unspecified	0.000	0.999	0.001
H11 Other disorders of conjunctiva	0.001	0.999	0.000
Z59 Problems related to housing and economic circumstances	0.001	0.999	0.000
B37.3 Candidiasis of vulva and vagina	0.000	0.999	0.001
B98.0 Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters	0.000	0.999	0.001
F60.5 Anankastic personality disorder	0.001	0.999	0.000
H81.8 Other disorders of vestibular function	0.001	0.999	0.000
K63.9 Disease of intestine, unspecified	0.000	0.999	0.001
M89.5 Osteolysis	0.001	0.999	0.000
Q87.8 Other specified congenital malformation syndromes, not elsewhere classified	0.001	0.999	0.000
S06.2 Diffuse brain injury	0.001	0.999	0.000
M89.99 Disorder of bone, unspecified (Site unspecified)	0.001	0.999	0.000
M89.98 Disorder of bone, unspecified (Other)	0.001	0.999	0.000
M89.96 Disorder of bone, unspecified (Lower leg)	0.001	0.999	0.000
M89.95 Disorder of bone, unspecified (Pelvic region and thigh)	0.001	0.999	0.000
M89.93 Disorder of bone, unspecified (Forearm)	0.001	0.999	0.000
M89.92 Disorder of bone, unspecified (Upper arm)	0.001	0.999	0.000
M89.91 Disorder of bone, unspecified (Shoulder region)	0.001	0.999	0.000
M89.90 Disorder of bone, unspecified (Multiple sites)	0.001	0.999	0.000
F40.9 Phobic anxiety disorder, unspecified	0.001	0.999	0.000
H90.5 Sensorineural hearing loss, unspecified	0.001	0.999	0.000
M89.6 Osteopathy after poliomyelitis	0.001	0.999	0.000
M89.4 Other hypertrophic osteo-arthropathy	0.001	0.999	0.000
M89.2 Other disorders of bone development and growth	0.001	0.999	0.000
M89.1 Epiphyseal arrest	0.001	0.999	0.000
R57.9 Shock, unspecified	0.001	0.999	0.000
R57.8 Other shock	0.001	0.999	0.000
R57.1 Hypovolaemic shock	0.001	0.999	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.001	0.999	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.001	0.999	0.000
M25.51 Pain in joint (Shoulder region)	0.001	0.999	0.000
Z63.9 Problem related to primary support group, unspecified	0.001	0.999	0.000
Z63.6 Dependent relative needing care at home	0.001	0.999	0.000
Z63.3 Absence of family member	0.001	0.999	0.000
Z63.2 Inadequate family support	0.001	0.999	0.000
Z63.1 Problems in relationship with parents and in-laws	0.001	0.999	0.000
F60 Specific personality disorders	0.001	0.999	0.000
N85.4 Malposition of uterus	0.000	0.999	0.001
R00.1 Bradycardia, unspecified	0.001	0.999	0.000
C58 Malignant neoplasm of placenta	0.000	0.999	0.001
C52 Malignant neoplasm of vagina	0.000	0.999	0.001
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.001	0.999	0.000
Y40 Systemic antibiotics	0.000	0.999	0.001
I61.8 Other intracerebral haemorrhage	0.001	0.999	0.000
J69.0 Pneumonitis due to food and vomit	0.001	0.999	0.000
Z63.8 Other specified problems related to primary support group	0.001	0.999	0.000
J67 Hypersensitivity pneumonitis due to organic dust	0.001	0.999	0.000
J64 Unspecified pneumoconiosis	0.001	0.999	0.000
S06.20 Diffuse brain injury (without open intracranial wound)	0.001	0.999	0.000
M89.3 Hypertrophy of bone	0.001	0.999	0.000
Q87.5 Other congenital malformation syndromes with other skeletal changes	0.001	0.999	0.000
Q87.3 Congenital malformation syndromes involving early overgrowth	0.001	0.999	0.000
Q87.2 Congenital malformation syndromes predominantly involving limbs	0.001	0.999	0.000
Q87.1 Congenital malformation syndromes predominantly associated with short stature	0.001	0.999	0.000
Q87.0 Congenital malformation syndromes predominantly affecting facial appearance	0.001	0.999	0.000
S06.7 Intracranial injury with prolonged coma	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations